Session 11: Novel Technologies to Overcome the Suppressive Tumor Microenvironment
Friday, November 5, 2021 | 10:50 AM – 12:15 PM PST
Moderator: Marco Gottardis, PhD, Janssen Research & Development, LLC
Introduction
Marco Gottardis, PhD, Janssen Research & Development, LLC
Improving CAR Responses against Solid Tumors with Conditional Payload Delivery
Gus Zeiner, PhD, Chimera Bioengineering
Combining Adenosine Pathway Inhibitors with Immunotherapy Agents in Prostate Cancer
Peter Fan, PhD, Teon Therapeutics
Mobilizing the Immune System with Bispecific Antibodies and Optimized Cytokines
John Desjarlais, PhD, Xencor
Microenvironment on Demand (MOD) – A Flexible Droplet-Microfluidic Platform to Accelerate Cell/Antibody Therapy Discoveries
Maithreyan Srinivasan, PhD, Scribe Biosciences